- Home
- IMAB vs CEV Comparison
IMAB vs CEV Comparison
Compare IMAB & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- CEV
- Stock Information
- Founded
- IMAB 2014
- CEV 1999
- Country
- IMAB United States
- CEV United States
- Employees
- IMAB N/A
- CEV N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- CEV Finance/Investors Services
- Sector
- IMAB Health Care
- CEV Finance
- Exchange
- IMAB Nasdaq
- CEV Nasdaq
- Market Cap
- IMAB 83.8M
- CEV 75.9M
- IPO Year
- IMAB 2020
- CEV N/A
- Fundamental
- Price
- IMAB $1.06
- CEV $10.41
- Analyst Decision
- IMAB Strong Buy
- CEV
- Analyst Count
- IMAB 3
- CEV 0
- Target Price
- IMAB $8.00
- CEV N/A
- AVG Volume (30 Days)
- IMAB 410.6K
- CEV 19.6K
- Earning Date
- IMAB 08-28-2024
- CEV 01-01-0001
- Dividend Yield
- IMAB N/A
- CEV 4.23%
- EPS Growth
- IMAB N/A
- CEV N/A
- EPS
- IMAB N/A
- CEV 0.36
- Revenue
- IMAB $3,492,091.00
- CEV N/A
- Revenue This Year
- IMAB N/A
- CEV N/A
- Revenue Next Year
- IMAB N/A
- CEV N/A
- P/E Ratio
- IMAB N/A
- CEV $29.36
- Revenue Growth
- IMAB N/A
- CEV N/A
- 52 Week Low
- IMAB $0.99
- CEV $8.83
- 52 Week High
- IMAB $2.54
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- IMAB 40.43
- CEV 33.56
- Support Level
- IMAB $1.02
- CEV $10.42
- Resistance Level
- IMAB $1.12
- CEV $10.67
- Average True Range (ATR)
- IMAB 0.08
- CEV 0.09
- MACD
- IMAB -0.01
- CEV -0.00
- Stochastic Oscillator
- IMAB 20.00
- CEV 0.00
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.